Vinci SA (LON:0NQM)

Verve Therapeutics Revenue

Vinci had revenue of 35.37B EUR in the half year ending June 30, 2025, with 7.51% growth. This brings the company's revenue in the last twelve months to 73.73B, up 3.26% year-over-year. In the year 2024, Vinci had annual revenue of 72.77B with 4.13% growth.

• Revenue (ttm): 73.73B EUR
• Revenue Growth: +3.26%
• P/S Ratio: 0.91
• Revenue / Employee: 260.99K EUR
• Employees: 282,481
• Market Cap: 57.54B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	72.77B	2.88B	4.13%
Dec 31, 2023	69.89B	7.37B	11.79%
Dec 31, 2022	62.51B	12.28B	24.46%
Dec 31, 2021	50.23B	6.11B	13.85%
Dec 31, 2020	44.12B	-4.83B	-9.87%